A New Horizon for Public Health: The European Respiratory Society Calls for a Definitive End to the Tobacco Epidemic on September 3, 2026 Posted by
Respiratory Care Excellence: AARC Members Making Headlines Across the Nation on September 3, 2026 Posted by
Rewriting the Paradigm: How New Discoveries in Dendritic Cell Biology Are Supercharging mRNA Cancer Vaccines on September 3, 2026 Posted by
Beyond Weight Loss: How a New Class of Drugs is Rewiring the Neuroscience of Addiction on September 3, 2026 Posted by
The Precipice of Global Conflict: Analyzing the Strategic Shift in Western-Russian Relations on September 3, 2026 Posted by
Clash of Titans: Vietnam vs. Thailand in the ASEAN Championship 2026 Final on September 3, 2026 Posted by
A New Horizon for Public Health: The European Respiratory Society Calls for a Definitive End to the Tobacco Epidemic on September 3, 2026 Posted by
Respiratory Care Excellence: AARC Members Making Headlines Across the Nation on September 3, 2026 Posted by
Rewriting the Paradigm: How New Discoveries in Dendritic Cell Biology Are Supercharging mRNA Cancer Vaccines on September 3, 2026 Posted by
Beyond Weight Loss: How a New Class of Drugs is Rewiring the Neuroscience of Addiction on September 3, 2026 Posted by
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Extension Study on August 10, 2026
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Study on August 2, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: Alkermes’ Alixorexton Shows Sustained Efficacy in Long-Term Clinical Study on July 25, 2026
Posted in Medical Innovations The Orexin Frontier: How Alkermes Is Positioning Its "Alixorexton" to Disrupt the Sleep Medicine Landscape on June 27, 2026
Posted in Sleep Health Advancing Sleep Medicine: Alkermes Secures Key Orphan Drug Designations for Alixorexton in Narcolepsy and Idiopathic Hypersomnia on June 17, 2026
Posted in Sleep Health Breakthrough in Sleep Medicine: Alkermes’ LUMRYZ Shows Promise for Idiopathic Hypersomnia in Phase 3 Trial on June 2, 2026 rifanmuazin
Posted in Sleep Health Breakthrough in Sleep Medicine: Alkermes’ LUMRYZ Shows Promise for Idiopathic Hypersomnia in Phase 3 Study on May 22, 2026 rifanmuazin
Posted in Sleep Health Breakthrough in Sleep Medicine: Alkermes’ REVITALYZ Study Offers New Hope for Idiopathic Hypersomnia Patients on May 15, 2026 rifanmuazin
